- Drug Pipelines
- November 2019
- 76 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- January 2020
- 100 Pages
Global
From €4582EUR$4,795USD£3,899GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$3,923USD£3,082GBP
- Report
- May 2023
- 87 Pages
Global
From €3500EUR$3,923USD£3,082GBP
- Report
- May 2022
- 57 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- April 2023
- 160 Pages
Global
From €5733EUR$5,999USD£4,878GBP
The Nicotine Addiction Drugs market is a subset of the Addiction Disorders Drugs market, which includes medications used to treat substance use disorders. Nicotine Addiction Drugs are used to help people quit smoking and reduce their dependence on nicotine. These drugs work by reducing cravings and withdrawal symptoms, and can be used in combination with behavioral therapies. Common Nicotine Addiction Drugs include nicotine replacement therapy (NRT) products such as patches, gum, and lozenges, as well as non-nicotine medications such as bupropion and varenicline.
Some companies in the Nicotine Addiction Drugs market include GlaxoSmithKline, Pfizer, Johnson & Johnson, Novartis, and Mylan. Show Less Read more
